American Journal of Cardiology
Volume 101, Issue 9 , Pages 1281-1284 , 1 May 2008

Prevalence of Metabolic Syndrome in Retired National Football League Players

  • Marc A. Miller, MD

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 212-241-6500; fax: 212-426-6376.
    • ,
  • Lori B. Croft, MD

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York
    • ,
  • Adam R. Belanger, BA

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York
    • ,
  • Abel Romero-Corral, MD

      Affiliations

    • Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
    • ,
  • Virend K. Somers, MD, PhD

      Affiliations

    • Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
    • ,
  • Arthur J. Roberts, MD

      Affiliations

    • Living Heart Foundation, Little Silver, New Jersey.
    • ,
  • Martin E. Goldman, MD

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York

Received 18 November 2007 ,Revised 19 December 2007 ,Accepted 19 December 2007.

References 

  1. Baron S, Rinsky R. NIOSH Mortality Study of NFL Football Players: 1959–1988. In: Cincinnati: Centers for Disease Control, National Institute for Occupational Safety and Health; 1994;p. 13
  2. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol. 2003;41:1547–1553
  3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555
  4. Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr. 2000;83:115–122
  5. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72:694–701
  6. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition (A consensus statement from the International Diabetes Federation). Diabet Med. 2006;23:469–480
  7. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–3072
  8. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414
  9. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005;112:666–673
  10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  11. Kraemer WJ, Torine JC, Silvestre R, French DN, Ratamess NA, Spiering BA, et al. Body size and composition of National Football League players. J Strength Cond Res. 2005;19:485–489
  12. Romero-Corral A, Somers VK, Sierra-Johnson J, Jensen MD, Thomas RJ, Squires RW, et al. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J. 2007;28:2087–2093
  13. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB, Wagenknecht LE, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112:3713–3721
  14. Ritchie JD, Miller CK, Smiciklas-Wright H. Tanita foot-to-foot bioelectrical impedance analysis system validated in older adults. J Am Diet Assoc. 2005;105:1617–1619
  15. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34:513–554
  16. Maron BJ, Araujo CG, Thompson PD, Fletcher GF, de Luna AB, Fleg JL, et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2001;103:327–334
  17. Maron BJ, Douglas PS, Graham TP, Nishimura RA, Thompson PD. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol. 2005;45:1322–1326
  18. Snow TK, Millard-Stafford M, Rosskopf LB. Body composition profile of NFL football players. J Strength Cond Res. 1998;12:146–149
  19. Harp JB, Hecht L. Obesity in the National Football League. JAMA. 2005;293:1061–1062
  20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  21. Laurson KR, Eisenmann JC. Prevalence of overweight among high school football linemen. JAMA. 2007;297:363–364
  22. Malina RM, Morano PJ, Barron M, Miller SJ, Cumming SP, Kontos AP, et al. Overweight and obesity among youth participants in American football. J Pediatr. 2007;151:378–382

 Dr. Belanger was supported by a generous grant from the Doris Duke Clinical Research Foundation, New York, New York. Dr. Somers is a consultant to Respironics, ResMed, Cardiac Concepts Inc. and Sepracor. Dr. Roberts (The Living Heart Foundation) has received funding from Phillips, Siemens, Pfizer, General Electric, ResMed and the Professional Athletes Trust Fund. The companies and organizations providing funding support to the Living Heart Foundation had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, and approval of the manuscript.

PII: S0002-9149(08)00054-4

doi: 10.1016/j.amjcard.2007.12.029

American Journal of Cardiology
Volume 101, Issue 9 , Pages 1281-1284 , 1 May 2008

Article Tools

* Image Usage & Resolution